Tag: Cancer: Breast
Dense-Dose Chemo of Little Benefit in Early Breast Cancer
No statistically significant improvement found in breast cancer recurrence-free survival
Adjuvant Endocrine Tx Adherence Disparity Due to Varying Costs
Racial/ethnic disparities in adherence explained by socioeconomic status, medication costs
Genetic Testing May Help ID VTE Risk in Breast Cancer Patients
Older breast cancer patients with increased genetic susceptibility receiving chemo have highest risk
Initiation, Adherence to AIs Low for Older Women With DCIS
About 45 percent of women initiated treatment with tamoxifen or aromatase inhibitors within one year
Older, Younger Women Equally Benefit From Breast Recon
No greater risk of complications for older patients; benefited as much as younger breast cancer patients
Rx Subsidy Ups Persistence to Breast Cancer Hormone Therapy
Greater discontinuation for white, black, and Hispanic patients not receiving subsidies
ACS: Contralateral Mastectomy Rates Up in Breast CA Patients
Reasons include thinking it is the best treatment for breast cancer and fear of recurrence
Bundled-Payment Program Deemed Better for Breast CA Care
Better adherence to quality indicators, outcome, and cost control over time in Taiwanese study
ACS: Contralateral Mastectomy Rates Up in Breast CA Patients
Reasons include thinking it is the best treatment for breast cancer and fear of recurrence
Downward Trend in U.S. Breast Cancer Mortality Continues
And the disparity between black and white women is narrowing, CDC says
